H.R. 8005 · 119th Congress · Crime and Law Enforcement
Stop Pills That Kill Act
Increases penalties for distributing fentanyl and other dangerous drugs. AI-read
- IntroducedMar 19, 2026 Done
- CommitteeWent to the floor without a report Not needed
- House floorPassed by voice vote · Sep 15, 2026 Done
- Senate floorIn Senate committee Current stage
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.
Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).
The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.
Congressional Research Service · summary of “Introduced in House” version · Mar 19, 2026
Who lobbies on it
1 organization · 2 filings · Q1 2026–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
American Society of Health-System Pharmacists
2 of 3 quarters
“…The Stop Pills That Kill Act (H.R. 8005), PRESS Act (H.R. 7184), and Fight Illicit Pill Presses Act (H.R. 5880), issues related to halting the unlawful production and availability of fentanyl, fentanyl analogues, and fentanyl-related substances. The States Handling Access to Reciprocity for Employment (SHARE) Act of…”
$750K lobbying spend in 2026 to date, all issuesQ3 2026 filing
Organizations that named H.R. 8005 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
16 actions · newest first- Sep 16, 2026Received in the Senate and Read twice and referred to the Committee on the Judiciary.
- Sep 15, 2026The title of the measure was amended. Agreed to without objection.
- Sep 15, 2026Motion to reconsider laid on the table Agreed to without objection.
- Sep 15, 2026On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5674-5675)
Show all 16 actionsShow fewer
- Sep 15, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
- Sep 15, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 8005.
- Sep 15, 2026Considered under suspension of the rules. (consideration: CR H5674-5676)
- Sep 15, 2026Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- Jul 21, 2026Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 43 - 6.
- Jul 21, 2026Committee Consideration and Mark-up Session Held
- Jul 20, 2026Committee Consideration and Mark-up Session Held
- Jul 15, 2026Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.
- Jul 15, 2026Subcommittee Consideration and Mark-up Session Held
- Mar 19, 2026Referred to the Subcommittee on Health.
- Mar 19, 2026Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 19, 2026Introduced in House
What members said about it
On the floor 2
From the Congressional Record: each member’s own words.
-
Mr. Speaker, I rise today in strong support of H.R. 8005, the Stop Pills That Kill Act, that my good friend from Colorado (Mr. Evans) has brought forward. The threat posed by illicit pill presses has risen as drug traffickers continue to press fentanyl, methamphetamine, and other illicit drugs into…
-
Mr. Speaker, I rise in support of H.R. 8005. This legislation addresses the supply chains that turn illicit chemicals into counterfeit pills by targeting the equipment, importation, and production behind the fentanyl crisis. Over the past several years, we have worked together in a strong,…
In releases and posts 2
-
Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement following the House passage of three Committee-led bills to combat the manufacturing of illicit drugs and to protect…
“I am glad to see the House take action to pass three House Energy and Commerce bills to build upon our work of combating illicit drugs that have devastated communities across our nation, especially here in Kentucky.”
-
Today, the U.S. House of Representatives passed a series of measures to protect American communities from public health threats.
“As Chairman of the Health Subcommittee, I am proud to have advanced these measures that target severe public health threats.”